Nishant Rajendra Tiwari – My 12-Step Thrombocytopenia Workup
Nishant Rajendra Tiwari, Hematology-Oncology Fellow at OU Health Stephenson Cancer Center, posted on X:
”My 12-Step Thrombocytopenia Workup
(Not Medical Advice)
1. Review baseline counts first. Rule out pseudothrombocytopenia.
2. Evaluate for critical conditions: TTP, HIT, or DIC?
• Assess heparin exposure – Calculate 4T score.
• Peripheral smear for schistocytes.
• Check LDH/Haptoglobin/Bilirubin, PT/aPTT/Fibrinogen.
3. Assess for acute leukemia or bone marrow involvement?
• Examine peripheral smear for abnormal/neoplastic cells.
• Consider imaging if clinically indicated.
• Do we need a bone marrow exam?
4. Active life-threatening bleeding? Do we need a platelet transfusion?
5. Review drug-induced thrombocytopenia. Always consult latest literature for implicated medications.
6. Investigate secondary causes:
• Nutritional deficiencies: B12, Folate, Copper, Zinc.
• Infections: HIV, Hepatitis, CMV, EBV, HSV (clinically guided).
• Sepsis leading to DIC.
• Endocrine disorders: TSH, Free T4.
7. Review imaging for cirrhosis/splenomegaly. If inconclusive, obtain abdominal ultrasound.
8. Consider mechanical causes: Dialysis/ECMO/IABP/cardiopulmonary bypass/artificial heart valve?
9. Evaluate pregnancy-related disorders: HELLP, AFLP, gestational thrombocytopenia.
10. Assess for autoimmune conditions if clinically warranted. Consider SLE and other rheumatological diseases.
11. Consider rare but serious differentials:
• CAPS, other TMA causes, PNH
• Post-transfusion purpura, HLH
• Pursue only with appropriate clinical suspicion
12. If no clear etiology identified, consider ITP as diagnosis of exclusion.
Key Clinical Considerations:
• Critically ill patients frequently have multifactorial thrombocytopenia [A combination of some of the above].
• Primary HLH presenting de novo in adults is exceedingly rare.
• Thrombocytopenia with thrombosis: Consider DIC, TTP, HIT, PNH, or VITT.
[Image AI Generated]”
Stay informed with Hemostasis Today.
-
Mar 13, 2026, 22:57Robert Hamilton: The Reality of Stroke Care and Why 81.6% Should be a Wake-Up call
-
Mar 13, 2026, 22:05Christoph B. Olivier: Annabel Hölzle Shared Critical Findings on HALT After TAVR
-
Mar 13, 2026, 21:29Timothy Glidewell: Genetic Signals of Platelet and Clotting Pathways in Cryptogenic Stroke
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH
-
Mar 13, 2026, 21:01Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
-
Mar 13, 2026, 20:50William Tembo: Understanding Stroke Through Landmark Clinical Trials
-
Mar 13, 2026, 20:35Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A
-
Mar 13, 2026, 20:11Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
-
Mar 13, 2026, 19:53Wolfgang Miesbach Announces the New English Edition of “Gene Therapy Concepts in the Treatment of Haemophilia”